№ lp_2_3_03933
File format: docx
Character count: 7847
File size: 22 KB
Note:
Year
Description of the material:
A suspension concentrate (SC) is a stable suspension of active ingredient(s) in an aqueous phase, intended for dilution with water before use, subject to specific physical property tests such as pourability, dispersibility, and suspensibility.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Type of document:
Technical specification draft
Scope:
Seed treatment formulations
Standard references:
CIPAC, FAO, ISO
Intended users:
Manufacturers and quality control laboratories
Active ingredient:
[ISO common name]
Physical tests:
Acidity, pH, pourability, wet sieve, suspensibility, particle size, adhesion to seeds
Storage conditions:
0 °C and 54 °C stability tests
Publication month:
Not specified
ISO Common Name:
Ametryn
Chemical Name:
4-N-ethyl-6-methylsulfanyl-2-N-propan-2-yl-1,3,5-triazine-diamine
Empirical Formula:
C9H17N5S
Relative Molecular Mass:
227.33
Boiling Point:
about 248°C (decomposition)
CAS Number:
834-12-8
CIPAC Code:
133
Method Status:
Provisional CIPAC method 2020
Based on:
Method supplied by Syngenta Crop Protection, USA
Document Type:
Analytical method
Analyte:
Ametryn
Formulations Covered:
Technical material (TC), Water Dispersible Granules (WG), Suspension Concentrates (SC)
Analytical Technique:
Capillary gas chromatography with flame ionization detection
Identity Tests:
Infrared spectrometry; Gas-liquid chromatography
Sampling Requirements:
Minimum 250 g (TC, WG) or 250 ml (SC)
Repeatability (TC):
10–13 g/kg at 968–972 g/kg
Reproducibility (TC):
19–20 g/kg at 968–972 g/kg
Repeatability (WG):
14 g/kg at 795 g/kg
Reproducibility (WG):
34 g/kg at 795 g/kg
Repeatability (SC):
7.7–10 g/kg at 435–447 g/kg
Reproducibility (SC):
19–20 g/kg at 435–447 g/kg
Year:
Not specified
Region / City:
Not specified
Subject:
Analytical Testing / Cannabis
Document Type:
Laboratory Standard Operating Procedure
Organization / Institution:
In-house Laboratory
Author:
Not specified
Intended Audience:
Laboratory analysts and supervisors
Effective Period:
Ongoing until revision
Approval Date:
Not specified
Revision Date:
Extracted from VAM-042 (v7.0)
Reference Method:
Eur. 2.5.12, MVR-010 (G-0134)
Safety Measures:
Use of personal protective equipment and handling guidelines for chemicals
Note:
Year
Document Type:
Technical Specification
Matrix:
Cannabis concentrates / extracts / resins
Customer:
In-house
Testing bundle:
{bundle}
Job number:
{jobs}
Method status:
Validated method issued for use
Purpose:
Analysis of cannabinoids in cannabis concentrates, extracts and resins
Analytes:
CBD, Δ9-THC, CBDA, THCA, Δ8-THC, CBC, CBCA, CBG, CBGA, CBN, CBDV, CBDB
Analytical technique:
High Performance Liquid Chromatography with Dual Diode Array Detection (HPLC-Dual DAD)
Instrument:
Agilent 1200 series HPLC with thermostated autosampler and dual diode array detectors
Column:
Agilent Zorbax Eclipse Plus C18 (100 × 2.1 mm × 1.8 µm)
Detection system:
Dual diode array detector with 60 mm and 3.7 mm UV cells
Mobile phase A:
Water with 0.1 % formic acid
Mobile phase B:
Methanol with 0.05 % formic acid
Calibration standard:
1000 mg/L CBD in methanol
Quantification range CBD and Δ9-THC:
0.03 (LOQ) to 90 % w/w
Quantification range CBDA and THCA:
0.03 (LOQ) to 10 % w/w
Quantification range other cannabinoids:
0.03 (LOQ) to 5 % w/w
Sample preparation:
Dissolution in THF and methanol followed by filtration through 0.2 µm regenerated cellulose filter
Sample storage condition:
Autosampler at 8 °C for up to 48 hours
Safety requirements:
Laboratory coat, safety glasses, disposable gloves and face shield when handling concentrated acids or bases
Responsible roles:
Analyst; Supervisor / Manager
Related validation references:
VR-056, VR-097, VR-105
Source method reference:
VAM-042 (v7.0)
Related procedures:
SOP-010, SOP-020, LOG-001, CCCV-034, CCCV-092, QSP-00
Year:
2023
Region / City:
In-house
Topic:
Residual solvents testing
Document Type:
Standard Operating Procedure
Organization:
Internal laboratory
Author:
Not specified
Target Audience:
Laboratory analysts, supervisors
Effective Period:
Ongoing
Approval Date:
Not specified
Revision Date:
Not specified
Year:
2020
Region / City:
Kentucky
Topic:
Personnel Policies
Document Type:
Policy
Organization / Institution:
Kentucky Board of Education
Author:
Superintendent
Target Audience:
Classified Employees
Period of Validity:
Ongoing
Approval Date:
07/27/2020
Date of Changes:
N/A
Note:
Year
Note:
Year
Year:
2023-2024
Region / City:
Massachusetts
Topic:
Disciplinary Disparities in Schools
Document Type:
Report
Organization:
Massachusetts Department of Elementary and Secondary Education
Author:
Massachusetts Department of Elementary and Secondary Education
Target Audience:
Educators, School Administrators, Policy Makers
Effective Period:
Winter 2023 – Winter 2026
Approval Date:
Winter 2023
Modification Date:
N/A
Note:
Year
Context description:
A procedural manual outlining the registration, suspension, and de-registration criteria for supply customers and their contractual arrangements within the WESM.
Year:
2023
Jurisdiction:
Kentucky
Legal basis:
KRS 158.150
Type of document:
School policy
Subject:
Student discipline and suspension
Responsible authorities:
Principal; Associate Principal; School Level Director; Superintendent
Maximum suspension length:
Up to ten (10) days per incident
Due process requirements:
Required prior to suspension, with exceptions for imminent danger
Special provisions:
Students with disabilities
Reporting requirements:
Written notice to Superintendent, parent/guardian, and school level Director
Related policies:
09.425; 09.426; 09.43; 09.431
Adoption date:
June 26, 2023
Regulatory references:
20 U.S.C. § 1400 et seq.; Goss v. Lopez (1975); Honig v. Doe (1988)
Year:
2026
Note:
Region/City
Subject:
Suspension Risk Assessment and Decision-Making Process
Document Type:
Policy/Procedure
Target Audience:
HR Representatives, Senior Managers, Trust Staff
Context:
A procedural document for assessing the necessity and implementation of suspension, including medical and professional registration considerations for colleagues under investigation or facing serious allegations.
Year:
2015
Note:
Region / City
Topic:
Temporary service suspension
Document type:
Notification
Target audience:
Person receiving services or their legal representative
Year:
2015
Region / City:
Not specified
Subject:
Temporary service suspension procedures
Document Type:
Policy
Agency / Institution:
DHS licensed provider
Author:
Not specified
Target Audience:
Program providers, case managers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Revision:
Not specified
Year:
2025
Region / city:
United Kingdom
Topic:
Immunization, Influenza Vaccine
Document Type:
Addendum
Organization / Institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Alex Allen, Greta Hayward
Target Audience:
Health professionals, Immunization Programs
Effective Period:
1 September 2025 - 1 April 2026
Approval Date:
6 August 2025
Modification Date:
23 July 2025
Background:
Live attenuated influenza vaccine nasal spray suspension (Fluenz®) updated formula
Contextual Description:
Addendum to UKHSA PGD v15.0 detailing updates to the influenza vaccine composition and active strains.
Year:
2025
Region / city:
England
Topic:
Influenza Vaccination
Document Type:
Patient Group Direction (PGD)
Authority / institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Jamie Lopez-Bernal, Greta Hayward
Target Audience:
Healthcare practitioners, immunisation staff
Period of validity:
From 1 September 2025 to 1 April 2026
Approval Date:
1 July 2025
Amendment Date:
25 June 2025
Year:
2024
Region / City:
EMEA
Therapeutic Area:
Allergic rhinitis
Document Type:
Product Information
Organization / Institution:
European Medicines Agency
Author:
Not specified
Target Audience:
Healthcare professionals
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2024
Region / City:
Australia
Topic:
Vaccine Approval, Respiratory Syncytial Virus
Document Type:
Clinical Submission
Organization / Institution:
GlaxoSmithKline Australia Pty Ltd
Author:
Unknown
Target Audience:
Health professionals, Policy makers
Effective Period:
Ongoing
Approval Date:
January 14, 2024
Change Date:
April 2024